Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aging does not affect beta-agonist responsiveness after methacholine-induced bronchoconstriction.

Annie Lin Parker1

  • 1Department of Pulmonary and Critical Care Medicine, Memorial Hospital of Rhode Island and Brown Medical School, Providence, Rhode Island, USA. Annie_Parker@brown.edu

Journal of the American Geriatrics Society
|February 14, 2004
PubMed
Summary

Bronchodilator response to beta-agonists remains consistent across age groups following methacholine-induced bronchoconstriction. Both beta-agonist monotherapy and combination therapy show similar effectiveness in improving lung function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Airway reactivity is a determinant of bronchodilator responsiveness after methacholine-induced bronchoconstriction.

The Journal of asthma : official journal of the Association for the Care of Asthma·2004
Same author

Respiratory muscle strength training with nonrespiratory maneuvers.

Journal of applied physiology (Bethesda, Md. : 1985)·2003
Same author

Ratio between forced expiratory flow between 25% and 75% of vital capacity and FVC is a determinant of airway reactivity and sensitivity to methacholine.

Chest·2003
Same author

Clinical variables are poor selection criteria for the use of methacholine bronchoprovocation in symptomatic subjects.

Respiratory care·2003
Same author

Pulmonary function characteristics in patients with different patterns of methacholine airway hyperresponsiveness.

Chest·2002

Area of Science:

  • Pulmonary Medicine
  • Pharmacology
  • Geriatrics

Background:

  • Methacholine challenge is used to assess airway hyperresponsiveness.
  • Bronchodilators are crucial in managing obstructive airway diseases.
  • The impact of aging on bronchodilator response requires further elucidation.

Purpose of the Study:

  • To compare bronchodilator responses after methacholine challenge across different age groups.
  • To evaluate the efficacy of a beta-agonist alone versus a combination therapy (beta-agonist and anticholinergic).

Main Methods:

  • Retrospective analysis of 764 subjects undergoing methacholine challenge.
  • Subjects received either metaproterenol (beta-agonist) or albuterol/ipratropium (combination).
  • Response measured by post-bronchodilator FEV1 change and recovery to 90% of baseline.

Related Experiment Videos

Main Results:

  • No significant difference in FEV1 response or recovery percentages between elderly and younger subjects.
  • Metaproterenol showed similar efficacy to the albuterol/ipratropium combination across all age groups.
  • P values > .05 indicated no statistically significant differences in treatment responses.

Conclusions:

  • Aging does not alter bronchodilator response to beta-agonists after methacholine-induced bronchoconstriction.
  • Beta-agonist monotherapy is as effective as combination therapy in this context.
  • These findings support consistent bronchodilator strategies regardless of patient age.